Keywords: new, indication, knoll, securon, uk, limited, received

New Indication For Knoll's Securon In UK

Article | 04 September 1997

- Knoll Limited in the UK has received a new license indication forits calcium antagonist Securon (verapamil sustained-release), for the secondary ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Covera-HS

Verapamil

Verelan PM

Go to drug listing